ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
scaffold_1_35 # 39495 # 39701 # -1 # ID=1_35;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.536	scaffold_1_35 	39495	39701	-	Strict	300	21.1718	AAC(2')-Ia	100.0	3002523	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(2')	GTGGCGAGTTTGTACTGTGATTTTGTATCCTCCCAGAGAGACGAGAATGCCGCACTCTCCGCCATAGCCGGTGCCGCGTATAGGGATGAGGCCAGAGAGACAGTCGAGGTGAATCGAAGTGGGGTTGCTTCTCAGCCGCACTTTCACGTGGAGCGACGTATTCAATTGTTGTTAAGAGATGGAGCAGGGTTATTGACGGCCTCATGA	MASLYCDFVSSQRDENAALSAIAGAAYRDEARETVEVNRSGVASQPHFHVERRIQLLLRDGAGLLTAS	MGIEYRSLHTSQLTLSEKEALYDLLIEGFEGDFSHDDFAHTLGGMHVMAFDQQKLVGHVAIIQRHMALDNTPISVGYVEAMVVEQSYRRQGIGRQLMLQTNKIIASCYQLGLLSASDDGQKLYHSVGWQIWKGKLFELKQGSYIRSIEEEGGVMGWKADGEVDFTASLYCDFRGGDQW	38.20	gnl|BL_ORD_ID|1682|hsp_num:0	1781	True	loose hit with at least 95 percent identity pushed strict
scaffold_1_1300 # 1435844 # 1435948 # -1 # ID=1_1300;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.533	scaffold_1_1300 	1435844	1435948	-	Strict	275	19.631	AAC(6')-32	100.0	3002586	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	GTGAATGGTCTGGATTACTTGCCCTGCTTTTGGGATCTAAGGAGGGGCGATTGGGGAGGAGAGGAGGAACTTGGAATGGCAATTGGGTTCAGTGCAGGGCGCTGA	MNGLDYLPCFWDLRRGDWGGEEELGMAIGFSAGR	MSPSKTPVTLRLMTERDLPMLHAWLNRPHIVEWWGGEEERPTLHEVVKHYLPRVLAEEAVTPYIAMLGDEPIGYAQSYVALGSGDGWWEDETDPGVRGIDQFLSNHTQLNQGLGTKLVQALVELLFSDPTVTKIQTDPAPNNHRAIRCYEKAGFVQQNVITTPDGPAVYMVQTRQAFERVRSAA	18.48	gnl|BL_ORD_ID|1482|hsp_num:0	1577	True	loose hit with at least 95 percent identity pushed strict
scaffold_1_1723 # 1808642 # 1808839 # -1 # ID=1_1723;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.520	scaffold_1_1723 	1808642	1808839	-	Strict	700	21.9422	FOX-4	100.0	3002158	protein homolog model	n/a	n/a	cephalosporin; cephamycin	antibiotic inactivation	FOX beta-lactamase	GTGACCATGTGTGCCGGAAACGGCGATATTTCGAGGCTTCAATCCCTGAATGGATTCGGGCACATAGTCGCTGAGACTTCTATTCCTGGTATGGCCGTCGCTGTGCTTCTCTCTATTCATAACAGTGCCAGACAGGCCCGCGTCCGTGATTCCGAGTCCATGATATGCGCGGCGCTTCGATTGGTTTGCTATAGCTGA	MTMCAGNGDISRLQSLNGFGHIVAETSIPGMAVAVLLSIHNSARQARVRDSESMICAALRLVCYS	MQQRRALALLMLGSLLLAPCTYASGEAPLTATVDGIIQPMLKAYRIPGMAVAVLKDGKAHYFNYGVANRESGQRVSEQTLFEIGSVSKTLTATLGAYAAVKGGFELDDKVSQHAPWLKGSAFDGVTMAELATYSAGGLPLQFPDEVDSNDKMQTYYRSWSPVYPAGTHRQYSNPSIGLFGHLAANSLGQPFEQLMSQTLLPKLGLHHTYIQVPESAMANYAYGYSKEDKPIRATPGVLAAEAYGIKTGSADLLKFVEANMGYQGDAALKSAIALTHTGFHSVGEMTQGLGWESYDYPVTEQVLLAGNSPAVSFQANPVTRFAVPKAMGEQRLYNKTGSTGGFGAYVAFVPARGIAIVMLANRNYPIEARVKAAHAILSQLAE	17.02	gnl|BL_ORD_ID|1626|hsp_num:1	1726	True	loose hit with at least 95 percent identity pushed strict
scaffold_1_2203 # 2310202 # 2310309 # -1 # ID=1_2203;partial=00;start_type=GTG;rbs_motif=GGxGG;rbs_spacer=5-10bp;gc_cont=0.500	scaffold_1_2203 	2310202	2310309	-	Strict	500	20.7866	OXA-20	100.0	3001415	protein homolog model	n/a	n/a	carbapenem; cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGGCGAGATTAATTAAGTGCGCTGTTGGAGATGATGGAGAAGGTGGATTTGAAGGGGTGATTGAGGAGTTAAGCGGAGATGCCGTTGATGGGCAGATGGGCTGGTGA	MARLIKCAVGDDGEGGFEGVIEELSGDAVDGQMGW	MIIRFLALLFSAVVLVSLGHAQEKTHESSNWGKYFSDFNAKGTIVVVDERTNGNSTSVYNESRAQQRYSPASTFKIPHTLFALDAGAVRDEFHVFRWDGAKRSFAGHNQDQNLRSAMRNSTVWVYQLFAKEIGENKARSYLEKLNYGNADPSTKSGDYWIDGNLAISANEQISILKKLYRNELPFRVEHQRLVKDLMIVEAKRDWILRAKTGWDGQMGWWVGWVEWPTGPVFFALNIDTPNRMEDLHKREAIARAILQSVNALPPN	13.16	gnl|BL_ORD_ID|1750|hsp_num:0	1853	True	loose hit with at least 95 percent identity pushed strict
scaffold_3_56 # 56313 # 56489 # 1 # ID=3_56;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.571	scaffold_3_56 	56313	56489	+	Strict	275	20.4014	AAC(6')-32	100.0	3002586	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	GTGGCGCTGATTGGCAATCGTGGCGACTCCATTGGCGGGGTGACTCATGCATGCGAACTCTCTTGGCGGGTGGTGGGAGACGGATGGTGGGTGGGTGGTGGTGGGGATGCTGCGTTGGGTGTTGGTACTGTATGTGTGTACGGGTATGGATTGTGGTGTGGTGTAATTCTGAGGTAA	MALIGNRGDSIGGVTHACELSWRVVGDGWWVGGGGDAALGVGTVCVYGYGLWCGVILR	MSPSKTPVTLRLMTERDLPMLHAWLNRPHIVEWWGGEEERPTLHEVVKHYLPRVLAEEAVTPYIAMLGDEPIGYAQSYVALGSGDGWWEDETDPGVRGIDQFLSNHTQLNQGLGTKLVQALVELLFSDPTVTKIQTDPAPNNHRAIRCYEKAGFVQQNVITTPDGPAVYMVQTRQAFERVRSAA	31.52	gnl|BL_ORD_ID|1482|hsp_num:0	1577	True	loose hit with at least 95 percent identity pushed strict
scaffold_5_737 # 756982 # 757173 # -1 # ID=5_737;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.505	scaffold_5_737 	756982	757173	-	Strict	1020	20.7866	tlrC	100.0	3002827	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic; tetracycline antibiotic; oxazolidinone antibiotic; phenicol antibiotic; pleuromutilin antibiotic	antibiotic target protection	ABC-F ATP-binding cassette ribosomal protection protein	ATGATTCAGCGCACAGCGCCAGGACAGGCCACTAAAGCTTTTGTTGTTGCGAGTAGAAGCCAGGACGACAATACCTGGCTTGAGGAGCATCTTTCGGATTGGACGGTCTACCGGTATGTCGTAGACAACTCACAGGCACAATACACTGTGCCCCAGAACAAGGGTCGAGAGGCAATGGTATATCTGAGGTAA	MIQRTAPGQATKAFVVASRSQDDNTWLEEHLSDWTVYRYVVDNSQAQYTVPQNKGREAMVYLR	MRTSPSSQLSLHGVTKRYDDRVVLSQVSLAISPGEKAGIIGDNGAGKSTLLRLLAGEERPDAGEVTVIAPGGVGYLPQTLGLPPRATVQDAIDLAMTELRVLEAELRRTEAALAEAATDEALQDALTAYARLTEQYEVRDGYGADARVDAALHGLGLPGLPRDRRLGTLSGGERSRLALAATLASQPELLLLDEPTNDLDDRAVHWLEEHLSGHRGTVVTVTHDRVFLDRLTATVLEVDGRGVSRHGDGYAGYLAAKAAERRRRQQQYDEWRAELDRNRRLAEANVARLDGIPRKMGKAAFGHGAFRARGRDHGAMSRVRNAKERVERLTANPVAPPADRLSLTARIATADGPGEAPAAELDGVVVGSRLRVPKLRLGAAERLLITGPNGAGKSTLLSVLAGELSPDAGAVSVPGRVGHLRQEETPWPAKLTVLEAFAHNRPGDRDEQADRRLSLGLFEPEALRLRVGELSYGQRRRIELARLVSEPVGLLLLDEPTNHLSPALVEELEEALTGYGGALVLVTHDRRMRSRFTGSHLELREGVVSGAR	11.50	gnl|BL_ORD_ID|1885|hsp_num:0	1997	True	loose hit with at least 95 percent identity pushed strict
scaffold_8_39 # 38441 # 38674 # 1 # ID=8_39;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.462	scaffold_8_39 	38441	38674	+	Strict	1800	23.8682	mexY	100.0	3003033	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; aminoglycoside antibiotic; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; acridine dye; phenicol antibiotic; disinfecting agents and intercalating dyes	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAAAATGGGCGAGCGGGATACTTCTACAAGTGAGGAGGAGATGGACAAGTGGGATACCTCTAAGAATGAGAAGAAAATGGGCAAGTGGGGTGCCTCCGTTGAGAACGACAAACGGACTGAGAGGATTAAAGAATGCAAAGACTGGAGTGAAAGGCGTGAGGAATGGTCTAAGAGGTGCACAGAATGGTACAGAATGGCACAAGAGGAACAAAGAATGGAAAGAATGCAATGA	MKMGERDTSTSEEEMDKWDTSKNEKKMGKWGASVENDKRTERIKECKDWSERREEWSKRCTEWYRMAQEEQRMERMQ	MARFFIDRPVFAWVISLLIVLAGVLAIRFLPVAQYPDIAPPVVNVSATYPGASAKVVEEAVTAIIEREMNGAPGLLYTKATSSTGQASLTLTFRQGVNANLAAVEVQNRLKIVESRLPESVRRDGIYVEKAADSIQLIVTLTSSSGRYDAMELGEIASSNVLQALRRVEGVGKVETWGAEYAMRIWPDPAKLTSMNLSASDLVNAVRRHNARLTVGDIGNLGVPDSAPISATVKVDDTLVTPEQFGEIPLAHPRDGGAIRLRDVARVEFGQSEYGFVSRVNQMTATGLAVKMAPGSNAVATAKRIRATLDELSRYFPEGVSYNIPYDTSAFVEISIRKVVSTLLEAMLLVFAVMYLFMQNFRATLIPTLVVPVALLGTFTVMLGLGFSINVLTMFGMVLAIGILVDDAIIVVENVERLMAEEGLSPHDATVKAMRQISGAIVGITVVLVSVFVPMAFFSGAVGNIYRQFAVTLAVSIGFSAFLALSLTPALCATLLRPIDADHHEKRGFFGWFNRAFLRLTGRYRNAVAGILARPIRWMLVYTLVIGVVALLFVRLPQAFLPEEDQGDFMIMVMQPEGTPMAETMANVGDVERYLAEHEPVAYAYAVGGFSLYGDGTSSAMIFATLKDWSERREASQHVGAIVERINQRFAGLPNRTVYAMNSPPLPDLGSTSGFDFRLQDRGGVGYEALVKARDQLLARAAEDPRLANVMFAGQGEAPQIRLDIDRRKAETLGVSMDEINTTLAVMFGSDYIGDFMHGSQVRKVVVQADRRKRLGIDDIGRLHVRNEQGEMGAAGDVRQGRLDPRPAATDPLQRLSLVQPRGPGRAGLQQREAMQAMEQLMQGTARGIRPRVVRPVLRRTPVAGAQAPALFALSVLIVFLALAALYESWSIPLAVILVVPLGVLGALLGVSLRGLPNDIYFKVGLITIIGLSAKNAILIIEVAKDHYQEGMSLLQATLEAARLRLRPIVMTSLAFGFGVVPLALSSGAGIRAQVAIGTGVLGGIVTATVLAVFLVPLFFLVVGRLFRLRKAPRTGNSPQIPTEQA	7.36	gnl|BL_ORD_ID|1687|hsp_num:0	1786	True	loose hit with at least 95 percent identity pushed strict
scaffold_8_423 # 442173 # 442337 # 1 # ID=8_423;partial=00;start_type=GTG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.570	scaffold_8_423 	442173	442337	+	Strict	700	20.4014	vanSB	100.0	3002932	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	vanS; glycopeptide resistance gene cluster	GTGAAGCAAGAGGCCGAATTGCCGTGCGAGAGAGAGACAGCGAGTGAGGTCGGTGGAAAAGATGGACGGAGTGTCGTCGCGAGAATGATTTCACAGCCCAGTCAAGCCAGAAGCAGGAAGTCCGGGTGCACAAAGCACGATCCCCCTACGCGAGGAGACTACTGA	MKQEAELPCERETASEVGGKDGRSVVARMISQPSQARSRKSGCTKHDPPTRGDY	MERKGIFIKVFSYTIIVLLLLVGVTATLFAQQFVSYFRAMEAQQTVKSYQPLVELIQNSDRLDMQEVAGLFHYNNQSFEFYIEDKEGSVLYATPNADTSNSVRPDFLYVVHRDDNISIVAQSKAGVGLLYQGLTIRGIVMIAIMVVFSLLCAYIFARQMTTPIKALADSANKMANLKEVPPPLERKDELGALAHDMHSMYIRLKETIARLEDEIAREHELEETQRYFFAAASHELKTPIAAVSVLLEGMLENIGDYKDHSKYLRECIKMMDRQGKTISEILELVSLNDGRIVPIAEPLDIGRTVAELLPDFQTLAEANNQRFVTDIPAGQIVLSDPKLIQKALSNVILNAVQNTPQGGEVRIWSEPGAEKYRLSVLNMGVHIDDTALSKLFIPFYRIDQARSRKSGRSGLGLAIVQKTLDAMSLQYALENTSDGVLFWLDLPPTSTL	12.08	gnl|BL_ORD_ID|469|hsp_num:0	499	True	loose hit with at least 95 percent identity pushed strict
scaffold_11_490 # 653948 # 654070 # 1 # ID=11_490;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.520	scaffold_11_490 	653948	654070	+	Strict	1000	20.7866	eptB	100.0	3005047	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGGAAGGCACTGTTGACCATGACCCGGGAGGTGCAGAAGATAACCCATATCCGAACGTCGAGACCGAGGAGGGGGCAATTTGGTTGTTATGCAGGGCTCCTGAGTGCTCAATATTCCAGTAA	MEGTVDHDPGGAEDNPYPNVETEEGAIWLLCRAPECSIFQ	MPQRQAVFYSSFSRFACMKYIRTMTQQKLSFWLALYIGWFMNVAVFFRRFDGYAQEFTFWKGLSGVVELVATVFVTFFLLRLLSLFGRRIWRILATLIVLFSAAASYYMTFLNVVIGYGIIASVMTTDIDLSKEVIGWHLILWLVVVSAPPLLFIWSNRCRHTLLRQLRTPGQRVKNVLIVVLAGLIVWGPIRLLELRQHDVERHSEVDMPSYGGVIANSYLPSNWLSALGLYAWAQVDESSDNKSLINPAKKFTYVAPEGLDDTYVVFIIGETTRWDHMGILDYSRNTTPELEKEKNLVAFRGYLCDTATKLSLRCMFVREGGAEDNPQRTLKEQNVFAVLHQLGFSGNLYAMQSEMWFYSNTMANNIAYREQIGAEPRNRGKSVDDMLLVDEMKRGMAQGNASGKHLIILHTKGSHFNYTQRYPRSFAQWKPECVGVDNKCSKAELINSYDNSVTYVDHFIVSVLDQLRDKKAIVFYAADHGESINEREHLHGTPRKMAPPEQFRVPMMVWMSDKYLENPDHAAAFAHLQQQAAMKVPRRHVELYDTIMGCLGYTSPDGGINENNNWCRWKK	6.97	gnl|BL_ORD_ID|2836|hsp_num:0	3791	True	loose hit with at least 95 percent identity pushed strict
scaffold_15_326 # 413060 # 413356 # 1 # ID=15_326;partial=00;start_type=GTG;rbs_motif=GGxGG;rbs_spacer=11-12bp;gc_cont=0.438	scaffold_15_326 	413060	413356	+	Strict	250	23.483	tet(D)	100.0	3000168	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	GTGGGTGTACTGGGTTGTGACGATTCCATCAACCGTCGCTATCATTTTGATTTTCCAGGCTTGGGTCAGAACTTCGAATCCAGGTTCAACAATGGCGGGATCATGGAGGAGGCTCCTAAGGATGGACAGAACCCACCCGGTATACAAAGATGTTCCAGTGGTGTAAAGCTCACTATTCCTTGGTCTGATAAATTGGGCAGACGGAGACTACGTAAGGTCATAGTTAGACCAGATAAAAAGCGCTTACTTGACAAATATCAGTTGTATATAATTGTGTCGGTATTTTTAGTATTGTGA	MGVLGCDDSINRRYHFDFPGLGQNFESRFNNGGIMEEAPKDGQNPPGIQRCSSGVKLTIPWSDKLGRRRLRKVIVRPDKKRLLDKYQLYIIVSVFLVL	MNKPAVIALVITLLDAMGIGLIMPVLPSLLREYLPEADVANHYGILLALYAVMQVCFAPLLGRWSDKLGRRPVLLLSLAGAAFDYTLLALSNVLWMLYLGRIISGITGATGAVAASVVADSTAVSERTAWFGRLGAAFGAGLIAGPAIGGLAGDISPHLPFVIAAILNACTFLMVFFIFKPAVQTEEKPAEQKQESAGISFITLLKPLALLLFVFFTAQLIGQIPATVWVLFTESRFAWDSAAVGFSLAGLGAMHALFQAVVAGALAKRLSEKTIIFAGFIADATAFLLMSAITSGWMVYPVLILLAGGGIALPALQGIISAGASAANQGKLQGVLVSLTNLTGVAGPLLFAFIFSQTQQSADGTVWLIGTALYGLLLAICLLIRKPAPVAATC	24.87	gnl|BL_ORD_ID|1222|hsp_num:0	1138	True	loose hit with at least 95 percent identity pushed strict
scaffold_15_359 # 441867 # 442112 # -1 # ID=15_359;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.520	scaffold_15_359 	441867	442112	-	Strict	1000	22.3274	eptA	100.0	3003576	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	GTGGTCATACTAATCCAGTGCACACAGATCGAAAACGTGTTTCATGACTTTCTTGCCCCTCGTTGCTGGGGAGAGCTCGAGCTTACCCTTGCCATGGGTGGCGAGCTGCGCTGCGGCCAAGCACAATTATATCCTAGCGGGCTTCTTAAAATAAATGATAATGATGGAGGATGCATGGACCACGAAGCTGACGATCTGATTAAACTGCCTGGAGCGTCCGGAGATGGAGGGAGCGGTGTGCGCTGA	MVILIQCTQIENVFHDFLAPRCWGELELTLAMGGELRCGQAQLYPSGLLKINDNDGGCMDHEADDLIKLPGASGDGGSGVR	MLKRLLKRPSLNLLAWLLLAAFYISICLNIAFFKQVLQALPLDSLHNVLVFLSMPVVAFSVINIVLTLSSFLWLNRPLACLFILVGAAAQYFIMTYGIVIDRSMIANIIDTTPAESYALMTPQMLLTLGFSGVLAALIACWIKIKPATSRLRSVLFRGANILVSVLLILLVAALFYKDYASLFRNNKELVKSLSPSNSIVASWSWYSHQRLANLPLVRIGEDAHRNPLMQNEKRKNLTILIVGETSRAENFSLNGYPRETNPRLAKDNVVYFPNTASCGTATAVSVPCMFSDMPREHYKEELAQHQEGVLDIIQRAGINVLWNDNDGGCKGACDRVPHQNVTALNLPDQCINGECYDEVLFHGLEEYINNLQGDGVIVLHTIGSHGPTYYNRYPPQFRKFTPTCDTNEIQTCTKEQLVNTYDNTLVYVDYIVDKAINLLKEHQDKFTTSLVYLSDHGESLGENGIYLHGLPYAIAPDSQKQVPMLLWLSEDYQKRYQVDQNCLQKQAQTQHYSQDNLFSTLLGLTGVETKYYQAADDILQTCRRVSE	14.81	gnl|BL_ORD_ID|611|hsp_num:0	516	True	loose hit with at least 95 percent identity pushed strict
scaffold_15_788 # 883542 # 883832 # 1 # ID=15_788;partial=00;start_type=ATG;rbs_motif=GGAG/GAGG;rbs_spacer=5-10bp;gc_cont=0.485	scaffold_15_788 	883542	883832	+	Strict	550	23.0978	IMI-4	100.0	3001861	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	IMI beta-lactamase	ATGTCGAGAAGCAAGCAGATGAATGTTGAAGAGGGCAGTAGGCAACTAGTTTATACTACGAAGTATGAGAAGGAACATTTCCAGGTTCTCATTTCTATTGGTGGACTCGGGACTACTCGGCCCTGTGTGGTGGCTTGTGTACTCTCACCTAGCGTTTCAAGACCCTGGATATTCAGGATTCGCCGTCTAAGGGATCCAAGCCTCCCAACCGGGAACACCTCTTCTCAGACTCTCTCCTCAGACCACGGGAGACCATACTCTGACAAGCAAAGCCATGTTGTAAGTGTATAA	MSRSKQMNVEEGSRQLVYTTKYEKEHFQVLISIGGLGTTRPCVVACVLSPSVSRPWIFRIRRLRDPSLPTGNTSSQTLSSDHGRPYSDKQSHVVSV	MSLNVKPSRIAILFSSCLVSISFFSQANTKGIDEIKDLETDFNGRIGVYALDTGSGKSFSYKANERFPLCSSFKGFLAAAVLKGSQDNQLNLNQIVNYNTRSLEFHSPITTKYKDNGMSLGDMAAAALQYSDNGATNIILERYIGGPEGMTKFMRSIGDKDFRLDRWELDLNTAIPGDERDTSTPAAVAKSLKTLALGNILNEREKETYQTWLKGNTTGAARIRASVPSDWVVGDKTGSCGAYGTANDYAVVWPKNRAPLIISVYTTKYEKEAKHEDKVIAEASRIAIDNLK	32.88	gnl|BL_ORD_ID|1299|hsp_num:0	1383	True	loose hit with at least 95 percent identity pushed strict
scaffold_17_675 # 788574 # 788681 # 1 # ID=17_675;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.306	scaffold_17_675 	788574	788681	+	Strict	275	19.2458	AAC(6')-34	100.0	3003989	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(6')	ATGTTGATGATTTTTGACTTTCAAGCAGAATCTCTGACATTTTATATACAGTTTTATCTTCTTAGAATGTTAATTAGAGAGAGAATTGAGGCTTTTGCGAGTCTTTGA	MLMIFDFQAESLTFYIQFYLLRMLIRERIEAFASL	MRIGDLIREDGGIAMLVYEAGPITVRELEEKDEISLASWLSNPDVLQYYEGRDNPHDVERVREHFYVDDDETRCIIKYEGKPIGYIQFYLLDEETLGEYGYNESDADCRTFATDQFIGEPDYWNRGIGTKLMTSMVEYLVFQRQADRIVMDPQAWNERAIACYEKCGFRKVRLLEKHEQHEGELRDCWIMEYRAERK	17.77	gnl|BL_ORD_ID|2294|hsp_num:0	2525	True	loose hit with at least 95 percent identity pushed strict
scaffold_18_283 # 303046 # 303138 # 1 # ID=18_283;partial=00;start_type=ATG;rbs_motif=GGA/GAG/AGG;rbs_spacer=11-12bp;gc_cont=0.398	scaffold_18_283 	303046	303138	+	Strict	500	19.2458	CARB-20	100.0	3003150	protein homolog model	n/a	n/a	penam	antibiotic inactivation	CARB beta-lactamase	ATGATATATAGCTATGTAGAAGATAAGATGTACGGAAGTAGAGGAATATCCCATAGCCGTGTGAGAGAGGTTCTCAAGTTTAAGGCACCATGA	MIYSYVEDKMYGSRGISHSRVREVLKFKAP	MKKLFLLVGLMVCSTVSYASKLNEDISLIEKQTSGRIGVSVWDTQTDERWDYRGDERFPLMSTFKTLACATMLSDMDSGKLNKNATARIDERNIVVWSPVMDKLAGQSTRIEHACEAAMLMSDNTAANLVLNEIGGPKAVTLFLRSIGDKATRLDRLEPRLNEAKPGDKRDTTTPNAMVNTLHTLMEDNALSYESRTQLKIWMQDNKVSDSLMRSVLPKGWSIADRSGAGNYGSRGISAMIWKDNYKPVYISIYVTDTDLSLQARDQLIAQISQLILEHYKES	10.60	gnl|BL_ORD_ID|1956|hsp_num:0	2110	True	loose hit with at least 95 percent identity pushed strict
scaffold_20_285 # 302038 # 302196 # 1 # ID=20_285;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.503	scaffold_20_285 	302038	302196	+	Strict	300	20.7866	AAC(3)-VIIa	100.0	3002541	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	AAC(3)	ATGCATGCAACGCCTTTGGTGGCGATGGGTTTCACCGACTGGCCACAGGAACTCATGCTCCAGATCCTTGACGACGCTGCCATAGGGTTACACGAGAAATGTAGTCTTGCGCGCGTAAATCATTTCATGCATCAGCTTGTCCTACCTCTCTTGTATTAG	MHATPLVAMGFTDWPQELMLQILDDAAIGLHEKCSLARVNHFMHQLVLPLLY	MDELALLKRSDGPVTRTRLARDLTALGLGDGDTVMFHTRMSAVGYVAGGPETVIGALRDVVGERGTLMVTCGWNDAPPYDFTDWPQTWQDARRAEHPAYDPVLSEADHNNGRLPEALRRRPGAVRSRHPDASFAALGAAATALTADHPWDDPHGPDSPLARLVAMGGRVLLLGAPLEALTLLHHAEALADAPGKRFVDYEQPILVDGERVWRRFHDIDSEDGAFDYSALVPEGTEAFEIIGRDMRAAGIGRRGTVGAADSHLFEARDVVDFGVAWMEEKLGRERGPGG	18.06	gnl|BL_ORD_ID|613|hsp_num:0	653	True	loose hit with at least 95 percent identity pushed strict
scaffold_27_144 # 160074 # 160211 # -1 # ID=27_144;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.543	scaffold_27_144 	160074	160211	-	Strict	400	20.7866	pgpB	100.0	3003920	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	lipid A phosphatase	ATGGGAGTGTCGGGGAAGGCCGACGATAACCACAAAGCGGAGGATTCCCACCACCCGGATTTCGCACTTGTTCCATGCATGACCGAACAGTGTCCGGCCCAAATTGCATTGCGCGGTTTGATGATTCCAGAGCTGTGA	MGVSGKADDNHKAEDSHHPDFALVPCMTEQCPAQIALRGLMIPEL	MEYILEVERNLFLTLNGVQHPLLDGFFYLISAKWTWVIMSIAFLFFLFYKKPTKEALFIVGAVLLSVLICDQLSSSFFKPFFARFRPSHHPDFIDYVKTVYGYRGGKYGFISGHTTNYISLALFTSRIFRNKFYTWTIWSVVALVIYSRIYIGVHFITDIIPGIAVGLIVGHFVYKVYLYARSRWLGASCPAHPSAVYAGDSIRLWTLSLIGFVFAMLCMSRQLTEILQYYVFLLF	19.07	gnl|BL_ORD_ID|2667|hsp_num:0	2397	True	loose hit with at least 95 percent identity pushed strict
scaffold_40_69 # 80538 # 80723 # -1 # ID=40_69;partial=00;start_type=GTG;rbs_motif=GGA/GAG/AGG;rbs_spacer=5-10bp;gc_cont=0.489	scaffold_40_69 	80538	80723	-	Strict	400	21.1718	vatH	100.0	3002845	protein homolog model	n/a	n/a	streptogramin antibiotic	antibiotic inactivation	streptogramin vat acetyltransferase	GTGCAGGAGGGAAGTGAGCAGGAAGATGGTAGTGAAGAGGGCTGCTGCTGCGAGGGAGGGGTCATATCTGTAGTATTTGAAGCCGTTATCTTTGGCCATGGCTGGTTATTTCAGGTTCTTCCGAATTGTACTTGGTTGAAGGTTCCCATAGGCTGCTTGGGTTGCTGGTTGTTAGAACGCAAATAA	MQEGSEQEDGSEEGCCCEGGVISVVFEAVIFGHGWLFQVLPNCTWLKVPIGCLGCWLLERK	MAEKLKGPNSNEMYPIAGNKSVQFVKPSLTRPNIIVGEFTYYDSKNGELFEDQVLYHYEIIGDRLIIGKFCSIGPGVTFIMNGANHRMDGSTYPFNIFGHGWEKHTPTLDMLPLKGDTIVGNDVWIGLDATIMPGVKIGDGAIIAAKSVVTKDVDPSTIVGGNPAKQIKKRFSESKIQELLKIKWWDFEDQVISDNIDAILSLDVEALNNISKEND	28.24	gnl|BL_ORD_ID|791|hsp_num:0	837	True	loose hit with at least 95 percent identity pushed strict
